Security key
107930208
BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX)
CUSIP: 107930208
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 61,766
- Total 13F value
- $181,057
- Share change
- +35,939
- SEC-reported price per share
- $2.94
- Number of holders
- 15
- Value change
- +$105,527
- Number of buys
- 4
- Number of sells
- 7
- Shares outstanding
- 4,043,321
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
15
Top holders
10
BCTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BriaCell Therapeutics Corp. SEC filings
BriaCell Therapeutics Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 107930208
Recent filing periods:
Ownership snapshot
Top reported holders of BCTX - BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
3i, LP
Disclosed value leader
Marc Lustig
Comparable rows
12/15
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 4.9%
3 rows are not safely comparable across share classes.
13D/G row: 3i, LP
Showing 1-6 of 15 holder rows.
Quick read
3i, LP leads the comparable SEC ownership view at 4.9%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 3i, LP's linked filing trail.
Comparable ownership
Top 5
3i, LP
4.9%
GROUP ONE TRADING LLC
0.07%
ROYAL BANK OF CANADA
0.02%
NATIONAL BANK OF CANADA /FI/
0.02%
SBI Securities Co., Ltd.
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 3i, LP |
13D/G
|
4.9%
|
$872,128
190,006 shares
|
-$821,582 | 31 Mar 2025 |
| GROUP ONE TRADING LLC |
13F
Company
|
0.07%
|
$10,822
2,925 shares
|
— | 31 Mar 2025 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.02%
|
$4,000
1,000 shares
|
— | 31 Mar 2025 |
| NATIONAL BANK OF CANADA /FI/ |
13F
Company
|
0.02%
|
$2,856
944 shares
|
— | 31 Mar 2025 |
| SBI Securities Co., Ltd. |
13F
Company
|
0.01%
|
$2,190
600 shares
|
— | 31 Mar 2025 |
| MORGAN STANLEY |
13F
Company
|
0.01%
|
$2,164
593 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
61,766
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2025 holders
15
Holder diff
14
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend